Native Valve Aspergillus Endocarditis Complicating Lung Transplantation

Journal of Heart and Lung Transplantation

Volumn 27, Issue 8, 2008, Pages 910-913

  Maher, Toby M ^a   Carby, Martin R ^a   Hall, Anne V ^a   Banner, Nicholas R ^a   Burke, Margaret M ^a   Dreyfus, Gilles D ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN; AMPHOTERICIN B DEOXYCHOLATE; AZATHIOPRINE; CASPOFUNGIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOSPORIN; CYCLOSPORIN A; GENTAMICIN; ITRACONAZOLE; METHYLPREDNISOLONE; PREDNISOLONE; SPORONOX; TEICOPLANIN; VANCOMYCIN; VORICONAZOLE;

ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FUMIGATUS; BRONCHOPULMONARY ASPERGILLOMA; CARDIOPULMONARY BYPASS; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CYSTIC FIBROSIS; ECHOCARDIOGRAPHY; ENDOCARDITIS; ENDOPHTHALMITIS; FEMALE; FORCED EXPIRATORY FLOW; FUNGUS CULTURE; GRAFT RECIPIENT; GRAFT REJECTION; HEART VALVE REPLACEMENT; HOSPITAL DISCHARGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG LAVAGE; LUNG TRANSPLANTATION; MITRAL VALVE REGURGITATION; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; ANTIFUNGAL AGENTS; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; ENDOCARDITIS; FATAL OUTCOME; FEMALE; HEART VALVES; HUMANS; LUNG TRANSPLANTATION;

EID: 47649129206     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.05.004     Document Type: Article

References (10)

1. Gilbey J.G., Chalermskulrat W., and Aris R.M. Aspergillus endocarditis in a lung transplant recipient. A case report and review of the transplant literature. Ann Transplant 5 (2000) 48-53
2. Iversen M., Burton C.M., Vand S., et al. Aspergillus infection in lung transplant patients: incidence and prognosis. Eur J Clin Microbiol Infect Dis 26 (2007) 879-886
3. Singhal P., Usuda K., and Mehta A.C. Post-lung transplantation Aspergillus niger infection. J Heart Lung Transplant 24 (2005) 1446-1447
4. Helmi M., Love R.B., Welter D., Cornwell R.D., and Meyer K.C. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest 123 (2003) 800-808
5. Pierrotti L.C., and Baddour L.M. Fungal endocarditis, 1995-2000. Chest 122 (2002) 302-310
6. Scherer M., Fieguth H.G., Aybek T., et al. Disseminated Aspergillus fumigatus infection with consecutive mitral valve endocarditis in a lung transplant recipient. J Heart Lung Transplant 24 (2005) 2297-2300
7. Saxena P., Clarke B., and Dunning J. Aspergillus endocarditis of the mitral valve in a lung-transplant patient. Tex Heart Inst J 34 (2007) 95-97
8. Monforte V., Roman A., Gavalda J., et al. Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation: study of risk factors. J Heart Lung Transplant 20 (2001) 1274-1281
9. Dummer J.S., Lazariashvilli N., Barnes J., Ninan M., and Milstone A.P. A survey of anti-fungal management in lung transplantation. J Heart Lung Transplant 23 (2004) 1376-1381
10. Groetzner J., Kaczmarek I., Wittwer T., et al. Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation. J Heart Lung Transplant 27 (2008) 1-6